ArticleEJIFCC2025
Navigating the Challenge: Selecting the Optimal Assay for Serum Albumin Measurement.
Article in EJIFCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Photometric techniques are the most common methods for measuring serum albumin, where albumin binds with an organic dye to form a complex. These methods are popular due to their simplicity, automation potential, speed, and cost-effectiveness, with bromocresol green (BCG) and bromocresol purple (BCP) being the most frequently used dyes. Case presentation: A 2-year-old boy presented with facial swelling, starting around the eyes in the morning and gradually spreading to the face, improving by evening, and accompanied by reduced urine output. He was diagnosed with nephrotic syndrome and treated with a high-calorie, high-protein diet, oral prednisolone, furosemide, and intravenous albumin. Despite treatment, his local laboratory's serum albumin level remained consistently low. However, tests from a private lab showed levels higher than the state lab. The nephrology team was informed of this discrepancy and chose to rely on the private lab's results. Conclusion: A comparison study between BCP and BCG methods found a good correlation overall, but Bland-Altman analysis revealed that BCG had a significant positive bias compared to BCP, explaining the lab discrepancies. The study underscored the importance of clinician awareness of different serum albumin measurement methods, noting that BCP is more specific and does not overestimate albumin in kidney disease patients like BCG does.
Indexed as
Identifiers
41098225PMC12519640What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.